Press Release

04th November 2026 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No. C/1, 'G' Block, Mumbai - 400 001. Bandra - Kurla Complex, Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir, Sub: Press Release on the unaudited (Standalone & Consolidated) financial results of the Company for the 02nd quarter and half-year ended 30th September 2026. With reference to the above-stated subject, please find enclosed herewith the Press Release on the unaudited (Standalone & Consolidated) financial results of the Company for the 02nd quarter and half- year ended 30th September 2026. The same will also be available on the website of the Company at https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015/Financial Information/Press Release. We request you to take this on record. Thanking you, Yours truly, For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer Enclosed: As above Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com CIN: L55101TG1973PLC040558 Press Release 4th Nov 2026, Hyderabad, India The Board of Directors of Krishna Institute of Medical Sciences Limited (KIMS Hospitals) today approved the financial results for the period ending 30th Sep 2026. A Snapshot of Consolidated Financial and Operational Highlights are as Follows: Q2 FY27 Updates: • Total Revenue of INR 1,363 Cr, a growth of 41.3% on YoY and 14.0% on QoQ basis. • EBITDA of INR 279 Cr, a growth of 34.0 % on YoY and 16.3 % on QoQ basis. • E BITDA margin stood at 20.5% vs. 20.1% in Q1 FY27 and 21.7 % in Q2 FY26. • PAT at INR 76 Cr in Q2 FY27 against INR 37 Cr and INR 72 Cr in Q1 FY27 and Q2 FY26 respectively. • Consolidated EPS for period ended 30th Sep 2026 of INR 1.8, a growth of 8.5% on YoY basis. • Cash and Cash Equivalents (including Cash, Bank balance, Deposits with maturity of less than 12 months and Investment in Mutual funds) of INR 420 Cr as on 30th Sep 2026. Q2 FY27 Financial Highlights - Consolidated: • Consolidated Revenue from Operations of INR 1,344 Cr, a growth of 39.9% on YoY and 14.0% on QoQ basis. • Consolidated EBITDA (Pre-INDAS) of INR 250 Cr, there is a growth of 24.7% on YoY and 12.7% on QoQ basis. • Consolidated EBITDA (Pre-INDAS and excluding Other Income) of INR 232 Cr, a growth of 17.9% on YoY and a growth of 12.6% on QoQ basis. Details on the table below: Amt in Crs Consolidated - Quarterly Results Consolidated - yearly Results Particulars Q2 FY27 Q1 FY27 Q2 FY26 QoQ YoY FY 26 FY 25 YoY Total Income 1,363.0 1,195.9 964.9 14.0% 41.3% 3,930.8 3,067.0 Less : Other Income 18.6 16.4 4.2 26.2 31.9 Revenue from Operations 1 ,344.4 1,179.5 960.7 14.0% 39.9% 3,904.6 3,035.1 28.6% PBT* 106.6 56.6 96.8 88.3% 10.1% 333.9 558.1 -40.2% Add : Interest 65.5 83.4 45.0 202.5 9 0.3 Add : Depreciation 120.7 1 00.8 66.1 283.2 177.2 Less : Exceptional items 13.2 - -0.3 -11.2 1 0.8 Less : Share of profit from associate, net of tax 0.7 1.0 - 2.6 - Reported EBITDA (Incl. other income) as per Financials 278.9 2 39.8 2 08.2 16.3% 34.0% 828.2 814.8 1.6% Less : Other Income 18.6 16.4 4.2 26.2 3 1.9 Less : INDAS 28.7 17.7 7.5 43.6 2 3.9 EBITDA Pre INDAS & Excl.Other Income 231.6 2 05.7 1 96.5 12.6% 17.9% 758.4 759.0 -0.1% EBITDA % to Revenue from Operations 17.2% 17.4% 20.5% 19.4% 25.0% * PBT inclusive of gain on fair valuation of call option, Statutory impact of new Labor Codes and Share of profit from associate. Operational Highlights Consolidated: Q2 FY27 Updates: • ARPOB grew by 14.9% and 2.3% on YoY and QoQ basis respectively. • ARPP grew by 9.9% and 1.2% on YoY and QoQ basis. Details on the table below: Consolidated - Quarterly Results Consolidated - yearly Results Particulars Q2 FY27 Q1 FY27 Q2 FY26 QoQ YoY FY 26 FY 25 YoY IP Volume 8 1,668 72,493 64,288 12.7% 27.0% 2,46,297 2,13,346 15.4% OP Volume 7,31,010 6,58,617 5,92,725 11.0% 23.3% 23,00,360 18,34,312 25.4% ARPOB (Rs) 48,277 47,200 42,016 2.3% 14.9% 44,644 39,158 14.0% ARPP (Rs) 1,65,577 1,63,573 1,50,624 1.2% 9.9% 1,59,575 1,43,293 11.4% GLIMPSES Of CLINICAL ACHIEVEMENTS – Q2 2026-27 KIMS Secunderabad • Critical Care & ECMO – The life of a 32-year-old woman doctor from Solapur, Maharashtra, who developed severe Acute Respiratory Distress Syndrome [ARDS] following influenza pneumonia, was saved using advanced ECMO support and comprehensive critical care. The patient was initially admitted to a hospital in Solapur where she was placed on mechanical ventilation. Considering the severity of her condition, the KIMS ECMO retrieval team travelled to Solapur and initiated ECMO support at the referring hospital itself. The patient was then safely transported overnight by road to KIMS Hospitals, Secunderabad, while remaining on ECMO support throughout the transfer. After 25 days of intensive treatment and rehabilitation, the patient made a complete recovery and was discharged in stable condition. • 100-YEAR-OLD FEMALE PATIENT - HIP SURGERY A 100-year-old female patient underwent HIP Surgery and recovered exceptionally well thanks to the exceptional expertise of the orthopaedic team. • Rare Intestinal Cancer - Successfully Treated While Preserving Transplanted Kidney. Doctors at KIMS Hospitals, Secunderabad have successfully treated a rare intestinal cancer in a 42-year-old woman while preserving her transplanted kidney which has been functioning for the past 17 years. She was diagnosed with high-grade intestinal lymphoma. A multidisciplinary team from Nephrology, Medical Oncology, Surgery and Critical Care carefully balanced chemotherapy with immunosuppressive treatment to control the cancer without affecting the transplanted kidney. After three cycles of chemo-immunotherapy, the tumour responded well but the patient developed a bowel fistula requiring emergency surgery. After the surgery, the patient completed the remaining chemotherapy cycles and a follow-up PET scan confirmed complete remission of the cancer. The case highlights the importance of multidisciplinary care in managing complex conditions involving organ transplant recipients. • Obstetrics & Gynaecology - High-Risk Pregnancy. Doctors successfully managed a high-risk pregnancy in a woman with a history of two consecutive second- trimester pregnancy losses, enabling her to carry her third pregnancy to term and deliver a healthy baby boy. The patient had previously undergone a conventional vaginal McDonald cerclage, which had failed to prevent pregnancy loss. In her third pregnancy, she underwent a laparoscopic trans-abdominal cerclage [TAC] at 14 weeks of gestation. Following the procedure, the patient was closely monitored throughout the pregnancy. She subsequently completed full term and delivered a healthy baby boy. KIMS Secunderabad reached a milestone of performing 300 Robotic surgeries on Davinci XI system. We are now the largest program in the state of Telangana and one of the highest volumes in Robotic units in the country. KIMS Kondapur • Cardiac Surgery - Rare & Complex Aortic Reconstruction with Suspended Animation. The cardiac surgical team successfully performed a rare and complex surgery on a 64 year old women bringing her back from the threshold of a planned clinical standstill. A multidisciplinary team evaluated the patient to reconstruct the main artery supplying blood to the brain and body. The surgical team had to induce a state of suspended animation. Following the flawless reconstruction, the patient was safely brought back to life as her heart was restarted and she was shifted to the ICU with minimal supports. She was off the ventilator in just a few hours. The success of this high-stakes [Showing first 8,000 characters — download PDF for full document]